Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spiegler, P. A.
Right arrow Articles by Groth, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spiegler, P. A.
Right arrow Articles by Groth, M. L.
(Chest. 2003;123:1895-1898.)
© 2003 American College of Chest Physicians

Rapid Pleurodesis for Malignant Pleural Effusions*

Peter A. Spiegler, MD, FCCP; Adam N. Hurewitz, MD, FCCP and Maritza L. Groth, MD, FCCP

* From Winthrop University Hospital, Mineola, NY.

Correspondence to: Peter Spiegler, MD, FCCP, 222 Station Plaza North, Suite 400, Mineola, NY 11501; e-mail: pspiegler{at}pulmonary.winthrop.org

Study objective: To determine the feasibility of rapid pleurodesis in patients with malignant pleural effusions in order to reduce hospital length of stay in patients with a limited life expectancy.

Design: Prospective case series.

Setting: Two university hospital programs.

Patients: Thirty-eight patients with symptomatic pleural effusions associated with malignancy.

Interventions: A 14F catheter was inserted percutaneously into the pleural space after radiographic confirmation of free fluid by lateral decubitus views. Following radiographic confirmation of complete fluid evacuation, a sclerosing agent (ie, talc slurry or bleomycin) was instilled into the pleural space. This was accomplished within 2 h of chest tube insertion, unless the tube was inserted in the evening or if the lung was trapped. After clamping the tube for 90 min, the pleural space was drained for 2 h, after which the chest tube was removed. The intervention was scored as "successful" if no radiographic evidence of fluid reaccumulation was noted at 4 weeks. A "partial successful" score indicated reaccumulation of fluid that did not produce symptoms and did not require repeat pleural drainage of any sort. All other outcomes were scored as "unsuccessful."

Measurements and results: Forty chest tubes were inserted into 38 patients. Four procedures revealed the presence of a trapped lung and did not result in any attempt at pleurodesis. Five patients who received pleurodesis died in less than 1 month and therefore were not evaluable. Two patients had technical problems with the chest tube and were not evaluable. Of the remaining 29 procedures, drainage procedures with pleurodesis were performed in 27 patients, a complete response was seen in 14 patients (48%), a partial response was seen in 9 patients (31%), and 6 patients (21%) did not respond to pleurodesis. Chemical pleurodesis was completed as an outpatient procedure in only two patients. In one of these, the outcome was unsuccessful. In the remainder, insertion of the chest tube in the evening or additional medical problems necessitated hospital admission, but the entire procedure was completed within 24 h.

Conclusions: Chemical pleurodesis can be accomplished with good results in < 24 h in the majority of patients with malignant pleural effusions.

Key Words: bleomycin • malignant • pleural effusion • pleurodesis • talc slurry




This article has been cited by other articles:


Home page
ChestHome page
A. R. Haas, D. H. Sterman, and A. I. Musani
Malignant Pleural Effusions: Management Options With Consideration of Coding, Billing, and a Decision Approach
Chest, September 1, 2007; 132(3): 1036 - 1041.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
T. Laisaar, V. Palmiste, T. Vooder, and T. Umbleja
Life expectancy of patients with malignant pleural effusion treated with video-assisted thoracoscopic talc pleurodesis
Interactive CardioVascular and Thoracic Surgery, June 1, 2006; 5(3): 307 - 310.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
S. Sartori, P. Tombesi, D. Tassinari, P. Ceccotti, I. Nielsen, L. Trevisani, and V. Abbasciano
Sonographically Guided Small-Bore Chest Tubes and Sonographic Monitoring for Rapid Sclerotherapy of Recurrent Malignant Pleural Effusions
J. Ultrasound Med., September 1, 2004; 23(9): 1171 - 1176.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. Sartori, D. Tassinari, P. Ceccotti, P. Tombesi, I. Nielsen, L. Trevisani, and V. Abbasciano
Prospective Randomized Trial of Intrapleural Bleomycin Versus Interferon Alfa-2b via Ultrasound-Guided Small-Bore Chest Tube in the Palliative Treatment of Malignant Pleural Effusions
J. Clin. Oncol., April 1, 2004; 22(7): 1228 - 1233.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American College of Chest Physicians.